Walser Wealth Management Company, A Ltd Liability Co
Position in NVO — Novo Nordisk A S
CIK 2112280
TAMPA, FL
Position in NVO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$215,682
New position
Shares Held
4,499
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,009
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walser Wealth Management Company, A Ltd Liability Co holds $4,936,411 across 8 Drug Manufacturers - General names. NVO ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,244 | $1,492,091 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
14,381 | $828,633 | |
| 3 | AMGN |
Amgen Inc
|
2,080 | $753,209 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,678 | $601,123 | |
| 5 | ABBV |
AbbVie Inc.
|
2,033 | $511,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,179 | $275,294 | |
| 7 | JNJ |
Johnson & Johnson
|
1,019 | $258,795 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
4,499 | $215,682 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,682 | 4,499 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||